222 related articles for article (PubMed ID: 21518778)
1. HER2 overexpression elicits a proinflammatory IL-6 autocrine signaling loop that is critical for tumorigenesis.
Hartman ZC; Yang XY; Glass O; Lei G; Osada T; Dave SS; Morse MA; Clay TM; Lyerly HK
Cancer Res; 2011 Jul; 71(13):4380-91. PubMed ID: 21518778
[TBL] [Abstract][Full Text] [Related]
2. The IL-6/JAK/Stat3 feed-forward loop drives tumorigenesis and metastasis.
Chang Q; Bournazou E; Sansone P; Berishaj M; Gao SP; Daly L; Wels J; Theilen T; Granitto S; Zhang X; Cotari J; Alpaugh ML; de Stanchina E; Manova K; Li M; Bonafe M; Ceccarelli C; Taffurelli M; Santini D; Altan-Bonnet G; Kaplan R; Norton L; Nishimoto N; Huszar D; Lyden D; Bromberg J
Neoplasia; 2013 Jul; 15(7):848-62. PubMed ID: 23814496
[TBL] [Abstract][Full Text] [Related]
3. Inactivation of p27kip1 promotes chemical hepatocarcinogenesis through enhancing inflammatory cytokine secretion and STAT3 signaling activation.
Guo J; Ma Q; Zhou X; Fan P; Shan T; Miao D
J Cell Physiol; 2013 Oct; 228(10):1967-76. PubMed ID: 23460367
[TBL] [Abstract][Full Text] [Related]
4. Antitumor activity of phenethyl isothiocyanate in HER2-positive breast cancer models.
Gupta P; Srivastava SK
BMC Med; 2012 Jul; 10():80. PubMed ID: 22824293
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of the autocrine IL-6-JAK2-STAT3-calprotectin axis as targeted therapy for HR-/HER2+ breast cancers.
Rodriguez-Barrueco R; Yu J; Saucedo-Cuevas LP; Olivan M; Llobet-Navas D; Putcha P; Castro V; Murga-Penas EM; Collazo-Lorduy A; Castillo-Martin M; Alvarez M; Cordon-Cardo C; Kalinsky K; Maurer M; Califano A; Silva JM
Genes Dev; 2015 Aug; 29(15):1631-48. PubMed ID: 26227964
[TBL] [Abstract][Full Text] [Related]
6. Differential interleukin-6/Stat3 signaling as a function of cellular context mediates Ras-induced transformation.
Leslie K; Gao SP; Berishaj M; Podsypanina K; Ho H; Ivashkiv L; Bromberg J
Breast Cancer Res; 2010; 12(5):R80. PubMed ID: 20929542
[TBL] [Abstract][Full Text] [Related]
7. The role of constitutively active signal transducer and activator of transcription 3 in ovarian tumorigenesis and prognosis.
Rosen DG; Mercado-Uribe I; Yang G; Bast RC; Amin HM; Lai R; Liu J
Cancer; 2006 Dec; 107(11):2730-40. PubMed ID: 17063503
[TBL] [Abstract][Full Text] [Related]
8. Autocrine/paracrine mechanism of interleukin-17B receptor promotes breast tumorigenesis through NF-κB-mediated antiapoptotic pathway.
Huang CK; Yang CY; Jeng YM; Chen CL; Wu HH; Chang YC; Ma C; Kuo WH; Chang KJ; Shew JY; Lee WH
Oncogene; 2014 Jun; 33(23):2968-77. PubMed ID: 23851503
[TBL] [Abstract][Full Text] [Related]
9. REG3A accelerates pancreatic cancer cell growth under IL-6-associated inflammatory condition: Involvement of a REG3A-JAK2/STAT3 positive feedback loop.
Liu X; Wang J; Wang H; Yin G; Liu Y; Lei X; Xiang M
Cancer Lett; 2015 Jun; 362(1):45-60. PubMed ID: 25779676
[TBL] [Abstract][Full Text] [Related]
10. STAT3-survivin signaling mediates a poor response to radiotherapy in HER2-positive breast cancers.
Kim JS; Kim HA; Seong MK; Seol H; Oh JS; Kim EK; Chang JW; Hwang SG; Noh WC
Oncotarget; 2016 Feb; 7(6):7055-65. PubMed ID: 26755645
[TBL] [Abstract][Full Text] [Related]
11. HER2-Driven Breast Tumorigenesis Relies upon Interactions of the Estrogen Receptor with Coactivator MED1.
Yang Y; Leonard M; Zhang Y; Zhao D; Mahmoud C; Khan S; Wang J; Lower EE; Zhang X
Cancer Res; 2018 Jan; 78(2):422-435. PubMed ID: 29187405
[TBL] [Abstract][Full Text] [Related]
12. HER2 Overexpression Triggers an IL1α Proinflammatory Circuit to Drive Tumorigenesis and Promote Chemotherapy Resistance.
Liu S; Lee JS; Jie C; Park MH; Iwakura Y; Patel Y; Soni M; Reisman D; Chen H
Cancer Res; 2018 Apr; 78(8):2040-2051. PubMed ID: 29382706
[TBL] [Abstract][Full Text] [Related]
13. IL-6 promotes head and neck tumor metastasis by inducing epithelial-mesenchymal transition via the JAK-STAT3-SNAIL signaling pathway.
Yadav A; Kumar B; Datta J; Teknos TN; Kumar P
Mol Cancer Res; 2011 Dec; 9(12):1658-67. PubMed ID: 21976712
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-21 links epithelial-to-mesenchymal transition and inflammatory signals to confer resistance to neoadjuvant trastuzumab and chemotherapy in HER2-positive breast cancer patients.
De Mattos-Arruda L; Bottai G; Nuciforo PG; Di Tommaso L; Giovannetti E; Peg V; Losurdo A; Pérez-Garcia J; Masci G; Corsi F; Cortés J; Seoane J; Calin GA; Santarpia L
Oncotarget; 2015 Nov; 6(35):37269-80. PubMed ID: 26452030
[TBL] [Abstract][Full Text] [Related]
15. Contribution of synergism between PHF8 and HER2 signalling to breast cancer development and drug resistance.
Liu Q; Borcherding NC; Shao P; Maina PK; Zhang W; Qi HH
EBioMedicine; 2020 Jan; 51():102612. PubMed ID: 31923801
[TBL] [Abstract][Full Text] [Related]
16. DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation.
Lai SC; Su YT; Chi CC; Kuo YC; Lee KF; Wu YC; Lan PC; Yang MH; Chang TS; Huang YH
J Exp Clin Cancer Res; 2019 Nov; 38(1):474. PubMed ID: 31771617
[TBL] [Abstract][Full Text] [Related]
17. The β2-adrenergic receptor and Her2 comprise a positive feedback loop in human breast cancer cells.
Shi M; Liu D; Duan H; Qian L; Wang L; Niu L; Zhang H; Yong Z; Gong Z; Song L; Yu M; Hu M; Xia Q; Shen B; Guo N
Breast Cancer Res Treat; 2011 Jan; 125(2):351-62. PubMed ID: 20237834
[TBL] [Abstract][Full Text] [Related]
18. STAT1 gene expression is enhanced by nuclear EGFR and HER2 via cooperation with STAT3.
Han W; Carpenter RL; Cao X; Lo HW
Mol Carcinog; 2013 Dec; 52(12):959-69. PubMed ID: 22693070
[TBL] [Abstract][Full Text] [Related]
19. HER2-associated radioresistance of breast cancer stem cells isolated from HER2-negative breast cancer cells.
Duru N; Fan M; Candas D; Menaa C; Liu HC; Nantajit D; Wen Y; Xiao K; Eldridge A; Chromy BA; Li S; Spitz DR; Lam KS; Wicha MS; Li JJ
Clin Cancer Res; 2012 Dec; 18(24):6634-47. PubMed ID: 23091114
[TBL] [Abstract][Full Text] [Related]
20. 15-Lipoxygenase-1 suppression of colitis-associated colon cancer through inhibition of the IL-6/STAT3 signaling pathway.
Mao F; Xu M; Zuo X; Yu J; Xu W; Moussalli MJ; Elias E; Li HS; Watowich SS; Shureiqi I
FASEB J; 2015 Jun; 29(6):2359-70. PubMed ID: 25713055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
